The vaccine, developed with the University of Oxford, has been described by the World Health Organization as probably the world’s leading candidate and the most advanced in terms of development. The suspension dims prospects for an early rollout amid reports that the United States was aiming for a fast-track approval before the November presidential election.

“SCOR well positioned to capture profitable growth opportunities”:Kessler

Sep 9, 2020

Kessler commented: “With the Covid-19 pandemic, SCOR has once again demonstrated its capacity to absorb major shocks combined with the resilience of its business model. Regarding the assessment of our exposure to the Covid-19 pandemic that we provided at the end of July 2020, on the P&C side, claims are developing as expected. On the life side, at this stage, claims experience is emerging better than expected. In addition, the pandemic has also exacerbated society’s growing aversion to risk, creating the conditions to drive stronger growth for the reinsurance industry.

First batch of Russia’s Covid-19 vaccine Sputnik V released into public

Sep 9, 2020

“The first batch of the ‘Gam-COVID-Vac’ (Sputnik V) vaccine for the prevention of the new coronavirus infection, developed by the Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of Russia, has passed the necessary quality tests in the laboratories of Roszdravnadzor (medical device regulator) and has been released into civil circulation,” the ministry said in a statement.

Boeing finds new problem with 787 that will delay deliveries

Sep 9, 2020

Boeing has recorded its first orders of the year for the grounded 737 Max, but a new flaw has surfaced in another of its planes, compounding the company’s struggle to recover during a pandemic that has undercut demand for new jetliners.

« Older Entries

Next Entries »

Briefs